STAT
SEPTEMBER 20, 2024
A second health worker who cared for a person hospitalized in Missouri with H5N1 bird flu developed mild respiratory symptoms but was not tested for influenza, the Centers for Disease Control and Prevention reported on Friday. The CDC said Missouri health officials didn’t learn that the health worker had symptoms until after the individual had recovered, too late to run a diagnostic test.
ALiEM - Pharm Pearls
SEPTEMBER 20, 2024
A 50-year-old male with insulin-dependent Type 2 Diabetes presented to the emergency department with three days of pain and swelling on the right side of his neck. He endorsed progression of his symptoms, reporting that he was now having fevers, myalgias, and intermittent difficulty swallowing solid foods. Additional Images Physical Exam Vitals : BP 153/96; HR 110; T 100.0°F; RR 16; O2 sat 97% General : Appears uncomfortable HEENT : Mild right-sided facial swelling.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 20, 2024
The U.S. Federal Trade Commission filed a lawsuit against the largest pharmacy benefit managers and their group purchasing organizations for allegedly anticompetitive practices that “artificially inflated” the price of insulin and, consequently, impeded patient access to the life-saving treatment. The administrative complaint accused CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx of creating a “perverse” system of rebates that favored
PharmaVoice
SEPTEMBER 20, 2024
Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
SEPTEMBER 20, 2024
The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration. Starting next flu season, people who want to order the vaccine to give it to themselves or their children at home will be able to do so.
PharmaVoice
SEPTEMBER 20, 2024
A promising epilepsy drug Ovid sold to Takeda recently missed the mark in late-stage trials. But Ovid believes it has other novel mechanisms that could deliver a CNS win.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
SEPTEMBER 20, 2024
The decision against Syfovre’s approval follows efforts by Apellis to have reviewers reevaluate clinical evidence multiple times and, according to an analyst, will lead to a restructuring of the company’s operations in Europe.
STAT
SEPTEMBER 20, 2024
The Food and Drug Administration has tapped Ross Segan, a former device industry exec and Army veteran, to lead its division charged with ensuring medical device safety. Segan was chief medical officer at Olympus from 2020 to 2023. Olympus is a leading distributor of endoscopes and the recipient of FDA warning letters claiming the company did not adequately address product defects — including instances where endoscope caps fell into patients’ bodies.
The Pharmacist
SEPTEMBER 20, 2024
The Pharmacist has launched a new and exclusive survey to gather opinions from community pharmacists, general practice pharmacists, and pharmacy contractors and owners in the UK. Our 2024 survey will cover a range of topics including, pharmacy closures, workload, recruitment, training, medicines shortages, independent prescribing and more. Take the survey here Depending on your job role, it […] The post Take our 2024 survey and potentially win £100 worth of vouchers appeared first on The P
STAT
SEPTEMBER 20, 2024
In 2013, I sat down at my computer and secured the URL t1international.com. I wanted a place where I could collect and share everything I was learning about the global insulin price crisis. I was only 25 years old, and I had already been living with type 1 diabetes for more than two decades. I had struggled with the ups and downs of high and low blood sugars, been hospitalized multiple times, and faced wildly high costs for my insulin and diabetes supplies in the United States.
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
Express Pharma
SEPTEMBER 20, 2024
GS1 India, a supply chain standards organisation set up under the Ministry of Commerce, Government of India, hosted the ‘Navigating the Future of Healthcare: From Vision to Reality’ conference at the India Habitat Centre, New Delhi. The event brought together 150+ participants including healthcare experts, government officials, pharmaceutical manufacturers, and industry leaders.
STAT
SEPTEMBER 20, 2024
As a pediatrician working for NYC Health + Hospitals (H+H), one of the largest public health care systems in the country, I have witnessed firsthand the challenges of providing quality care to patients from all walks of life. Whether they’re American-born or newly arrived children, my colleagues and I are tasked with ensuring they get the medical attention they need.
pharmaphorum
SEPTEMBER 20, 2024
Astellas is ready to launch its first digital health product in the US, called Digitiva, which provides at-home monitoring of people with heart failure
STAT
SEPTEMBER 20, 2024
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some psychiatric side effects like anxiety and sleep disturbances — results that pose a challenge to the pharma giant’s efforts to find novel obesity drugs that could extend its success from its blockbuster Wegovy. A Phase 2a trial tested monlunabant, a pill that inhibits CB1 receptors that Novo got through its acquisition of Inversago Pharma last year.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Express Pharma
SEPTEMBER 20, 2024
The United States Food & Drug Administration (USFDA) completed a routine Good Manufacturing Practice (GMP) inspection at Dr Reddy’s Laboratories’ R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad. The inspection was conducted from September 16 to September 20, 2024. The inspection closed with zero observations.
STAT
SEPTEMBER 20, 2024
Amid a steady rise in research misconduct allegations over the past decade, the Department of Human Health and Services last week updated its guidance on how universities and other institutions investigate claims. It’s a move that experts say is a step in the right direction — though many warn that more systemic change is needed to address mounting concerns over data manipulation and other issues in the sciences.
pharmaphorum
SEPTEMBER 20, 2024
J&J's target of $5bn in sales for Rybrevant has moved a step closer, after an FDA approval for second-line treatment of EGFR+ NSCLC
STAT
SEPTEMBER 20, 2024
WASHINGTON — A federal appeals court ruled that three organizations, including the brand drug lobby PhRMA, can challenge Medicare’s drug price negotiation program in a lower court based in Texas.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
SEPTEMBER 20, 2024
The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.
STAT
SEPTEMBER 20, 2024
Like all living things, cancer cells need to eat, and scientists have long tried to figure out how to starve tumors to death. A lot of that effort has focused on stifling the cells’ ability to digest glucose, a simple sugar thought to be the main food source for cancer. The glucose route has been ineffective, says William Lowry, a biologist at the University of California, Los Angeles.
The Pharmacist
SEPTEMBER 20, 2024
People who eat more ultra-processed food (UPF) may have a higher risk of developing type 2 diabetes, a study has suggested. Researchers found that for every 10% increase in the proportion of a person's total daily food intake that comes from UPF, there is a 17% increase in the risk of developing a new case […] The post Replacing ultra-processed foods in diet may reduce type 2 diabetes risk appeared first on The Pharmacist.
STAT
SEPTEMBER 20, 2024
The Food and Drug Administration on Friday approved the first treatment for Niemann-Pick disease, type C, the culmination of years of advocacy and stutter-start drug development efforts in the rare neurological condition. The drug, known chemically as arimoclomol and now marketed as Miplyffa, was one of three that companies put in clinical trials around a decade ago, after parents of children with the disease pushed scientists and companies to focus on the condition and helped steer their effort
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
SEPTEMBER 20, 2024
The Indian pharmaceuticals sector will log a revenue growth of 8-10 per cent this fiscal, after ~10 per cent growth last year, supported by healthy exports to regulated markets (1), recovery in exports to semi-regulated markets (1) and steady domestic demand. The resultant improvement in operating leverage along with easing pricing pressure in the US generics market will improve operating margins by 70-80 basis points (bps) to ~22.5 per cent this fiscal.
STAT
SEPTEMBER 20, 2024
If you’re a health care worker who vibes with this Tiktok , have I got a newsletter for you: STAT’s Health Care, Inc. by Bob Herman (#BobHive rise up), who makes the crushing monetization of our health at least kind of fun? (Important info: If you’re already a subscriber to HCI, get a friend to sign up at this link with the referral code provided in Monday’s newsletter and be entered to win a $100 bookshop.org gift certificate!
BioPharma Dive
SEPTEMBER 20, 2024
A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.
STAT
SEPTEMBER 20, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharmaceutical Business Review
SEPTEMBER 20, 2024
The product is the result of a collaboration with the Agency for Science, Technology, and Research (A*STAR), featuring patented active pH control technology to address the skin condition. Hand eczema is a condition affecting a significant portion of healthcare workers due to frequent hand washing. The product’s innovation lies in its ability to sustainably lower skin pH, which is vital for maintaining skin health.
STAT
SEPTEMBER 20, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we see Ginkgo pivot into AI, becoming yet another contender in a crowded market. Also, we see more documents destroyed at an Indian drug manufacturing plant, and offer up a fabulous podcast.
The Thyroid Pharmacist
SEPTEMBER 20, 2024
I’ve always had a passion for advocating for, and serving, vulnerable and underserved individuals. Before becoming the Thyroid Pharmacist as a result of my own Hashimoto’s journey, I was focused on helping geriatric adults, people with mental health issues, and individuals with special needs. In high school, I assisted at a recreational program for kids with developmental disabilities.
STAT
SEPTEMBER 20, 2024
In 2012, British journalist Michael Mosley sparked a global trend with his BBC documentary, “Eat, Fast and Live Longer.” Seeking a simple way to get healthy without growing his to-do list, Mosley discovered fasting. “What I discovered was truly surprising — it involves no pills, no injections and no hidden costs. It’s all a matter of what you eat.
pharmaphorum
SEPTEMBER 20, 2024
Discover five effective patient travel strategies to improve diversity in clinical research enrolment. Learn how to enhance inclusivity and representation in your research studies.
World Pharma News
SEPTEMBER 20, 2024
Today, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used safely and effectively for many years. It was initially approved by the FDA in 2003 for use in individuals 5 through 49 years of age, and in 2007, the FDA approved the use of FluMist to include children
Expert insights. Personalized for you.
364 
Let's personalize your content